The high prevalence of metabolic syndrome in polymyositis

Nenhuma Miniatura disponível
Citações na Scopus
26
Tipo de produção
article
Data de publicação
2014
Editora
CLINICAL & EXPER RHEUMATOLOGY
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, v.32, n.1, p.82-87, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective Metabolic syndrome (MetS) is a cluster of metabolic abnormalities that are associated with increased cardiovascular diseases (CVD). MetS has been systematically evaluated in all systemic autoimmune rheumatic diseases except for polymyositis (PM). This study aimed to evaluate the frequency of MetS in PM patients and analyse the possible association of MetS with traditional risk factors of CVD and PM-related clinical and laboratory features. Methods The present cross-sectional, single-centre study included 35 consecutive PM patients (Bohan and Peter, 1975) and 70 healthy controls. MetS diagnosis was determined according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII). Results The age, gender and ethnicity distributions between the PM and control groups were comparable (p>0.050). The median PM disease duration was 5 years. Compared with healthy subjects, PM patients had higher prevalence of MetS (45.7% vs. 20.0%, p=0.011). In an additional univariate analysis of PM patients with (n=26) and without (n=19) MetS revealed that patients with this complication were older (56.1 +/- 7.8 vs. 44.3 +/- 12.8 years; p=0.002) with more cumulative prednisolone doses, higher scores on the health assessment questionnaire and on the physician visual analogue scale (p<0.050). Disease duration was comparable between both groups (p>0.050). Conclusion MetS and CVD risks are highly prevalent in PM. Monitoring for and early treatments of modifiable risk factors for CVD in PM patients are necessary.
Palavras-chave
cardiovascular diseases, inflammatory myopathies, metabolic syndrome, polymyositis
URI
https://observatorio.fm.usp.br/handle/OPI/7384
Referências
  1. BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706
  2. Bruce Bonnie, 2003, Health Qual Life Outcomes, V1, P20, DOI 10.1186/1477-7525-1-20
  3. Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005
  4. Chen YJ, 2008, ARCH DERMATOL, V144, P1571, DOI 10.1001/archderm.144.12.1571
  5. Chung CP, 2008, ATHEROSCLEROSIS, V196, P756, DOI 10.1016/j.atherosclerosis.2007.01.004
  6. Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
  7. de Moraes MT, 2013, ARTHRIT CARE RES, V65, P793, DOI 10.1002/acr.21879
  8. Dessein PH, 2006, ARTHRITIS RHEUM, V54, P2765, DOI 10.1002/art.22053
  9. Dessein PH, 2013, CLIN EXP RHEUMATOL, V31, P53
  10. Dimachkie MM, 2009, FRONT NEUROL NEUROSC, V26, P126, DOI 10.1159/000212374
  11. Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I
  12. Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
  13. Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444
  14. Gaubitz M, 2006, RHEUMATOLOGY, V45, P3, DOI 10.1093/rheumatology/kel282
  15. Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092
  16. Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
  17. Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683
  18. Kontunen P, 2011, SCAND J RHEUMATOL, V40, P256, DOI 10.3109/03009742.2010.548827
  19. LEGG AT, 1932, PRINCIPLES PRACTICE
  20. Linklater H, 2013, CLIN EXP RHEUMATOL, V31, P767
  21. Manzi S, 1999, ARTHRITIS RHEUM, V42, P51, DOI 10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D
  22. Matsudo SM, 2001, REV BRAS ATIV FIS SA, V6, P5
  23. Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696
  24. Prieto S, 2010, AUTOIMMUN REV, V9, pA330, DOI 10.1016/j.autrev.2009.11.006
  25. REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595
  26. Sabio JM, 2008, LUPUS, V17, P849, DOI 10.1177/0961203308093554
  27. Toms TE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2765
  28. Wang H, 2013, J EUR ACAD DERMATOL, V27, P175, DOI 10.1111/j.1468-3083.2011.04437.x
  29. Westhovens R, 1997, BRIT J RHEUMATOL, V36, P444

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/17
Artigos e Materiais de Revistas Científicas - ODS/03